Microbial immunology: A new mechanism for immune subversion

Current Biology

Volumn 8, Issue 3, 1998, Pages

  Lachmann, Peter J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032576735     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0960-9822(98)70057-0     Document Type: Article

References (18)

1. Keusch GT: Immune responses in parasitic diseases. Part A: general concepts. Rev Infect Dis 1982, 4:751-755.
2. Hall BF, Joiner KA: Strategies of obligate intracellular parasites for evading host defences. Immunol Today 1991, 12:22-27.
3. Marrack P, Kappler J: Subversion of the immune response by pathogens. Cell 1994, 76:323-332.
4. Huemer HP, Wang Y, Garrad P, Koistinen V, Oppermann S: Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein. Immunology 1993, 79:639-647.
5. Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B: Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 1990, 250:827-830.
6. Albrecht JC, Nicholas J, Cameron KR, Newman C, Fleckenstein B, Honess RW: Herpesvirus saimiri has a gene specifying a homolog of the cellular membrane glycoprotein CD59. Virology 1992, 190:527-530.
7. Bramley JC, Davies A, Lachmann PJ: Herpesvirus saimiri CD59-baculovirus expression and characterisation of complement inhibitory activity. Biochem Soc Trans 1997, 25:354S.
8. Marikovsky M, Parizade M, Arnon R, Fishelson Z: Complement regulation on the surface of cultured schistosomula and adult worms of Schistosoma mansoni. Eur J Immunol 1990, 20:221-227.
9. Gustafson KS, Vercellotti GM, Bendel CM, Hostetter MK: Molecular mimicry in Candida albicans. Role of an integrin analogue in adhesion of the yeast to human endothelium. J Clin Invest 1991, 87:1896-1902.
10. Schorey JS, Carroll MC, Brown EJ: A macrophage invasion mechanism of pathogenic mycobacteria. Science 1997, 277:1091-1093.
11. Zimmerli S, Edwards S, Ernst JD: Selective receptor blockade during phagocytosis does not alter the survival and growth of M. tuberculosis in human macrophages. Am J Respir Cell Mol Biol 1996, 15:760-770.
12. Stroud RM, Mayer MM, Miller JA, McKenzie AT: C'2ad, an inactive derivative of C'2 released during decay of EAC'4,2a. Immunochemistry 1966, 3:163-176.
13. Polley MJ, Muller-Eberhard HJ: The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase. J Exp Med 1968, 128:533-551.
14. Gigli I, Fujita T, Nussenzweig V: Modulation of the classical pathway C3 convertase by plasma proteins, C4 binding protein and C3b inactivator. Proc Natl Acad Sci USA 1979, 76:6596-6600.
15. Kinoshita T, Dodds AW, Law SK, Inoue K: The low C5 convertase activity of the C4A6 allotype of human complement component C4. Biochem J 1989, 261:743-748.
16. Lachmann PJ: Complement deficiencies -genetic and acquired. In Clinical Aspects of Immunology. Edited by Lachmann PJ, Peters DK, Rosen FS and Walport MJ. Oxford: Blackwell Scientific Publications; 1993:1287-1304.
17. Carrell R: Alpha1-antitrypsin deficiency and tuberculosis. Trends Biochem Sci 1983, 8:10.
18. Meindl RS: Hypothesis: a selective advantage for cystic fibrosis heterozygotes. Am J Phys Anthropol 1987, 74:39-45.